您的位置:首页 > 产品中心 > Anti-BRCA2 (Ab-1) Mouse mAb (2B)
Anti-BRCA2 (Ab-1) Mouse mAb (2B)
产品别名
Anti-BRCA2 (Ab-1) Mouse mAb (2B)
Anti-Breast Cancer Susceptibility Protein
产品性质
Quality Level【质量水平】 | 100 |
biological source【生物来源】 | mouse |
antibody form【抗体形式】 | purified antibody |
antibody product type | primary antibodies |
clone【克隆】 | 2B, monoclonal |
form【形式】 | liquid |
contains【包含】 | ≤0.1% sodium azide as preservative |
species reactivity | human |
manufacturer/tradename | Calbiochem® |
storage condition【储存条件】 | OK to freeze |
isotype【同位素/亚型】 | IgG2b |
shipped in【运输】 | wet ice |
storage temp.【储存温度】 | −20℃ |
packaging【包装】 | 100 μg in Glass bottle Please refer to vial label for lot-specific concentration. |
基本信息
General description【一般描述】 | Purified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with myeloma cells. Recognizes the ~460 kDa BRCA2 protein. Anti-BRCA2 (Ab-1), mouse monoclonal, clone 2B, recognzies the ~460 kDa BRCA2 protein in cells expressing a wild type BRCA2 gene. It is validated for Western blotting and immunoprecipitation. Recognzies the ~460 kDa BRCA2 protein in cells expressing a wild type BRCA2 gene. Sold under license of U.S. Patent 5,753,441 and 6,162,897. |
Immunogen【免疫原】 | a recombinant protein consisting of amino acids 1651-1821 of human BRCA2 fused to GST Human |
Application【应用】 | Immunoblotting (2 µg/ml) Immunoprecipitation (2 µg) |
Warning【警告】 | Toxicity: Standard Handling (A) |
Physical form【外形】 | In PBS. |
Reconstitution【重悬】 | Following initial thaw, aliquot and freeze (-20°C). |
Analysis Note【分析说明】 | Positive Control MCF7 cells |
Other Notes【其他说明】 | Andres, J.L., et al. 1998. Oncogene16, 2229. Chen, J., et al. 1998. Mol. Cell2, 317. Chen, P.L., et al. 1998. Proc. Natl. Acad. Sci. USA95, 5287. Marmorstein, L.Y., et al. 1998. Proc. Natl. Acad. Sci. USA95, 13869. Connor, F., et al. 1997. Nat. Genet.17, 423. Sharan, S.K., et al. 1997. Nature386, 804. Ludwig, T., et al. 1997. Genes Dev.11, 1226. Mizuta, R., et al. 1997. Proc. Natl. Acad. Sci. USA94, 6927. Rajan, J.V., et al. 1997. Dev. Biol.184, 385. Suzuki, A., et al. 1997. Genes Dev.11, 1242. Wong, A.K.C., et al. 1997. J. Biol. Chem.272, 31941. Cannon-Albright, L.A. and M.H. Skolnick. 1996. Semin. Oncol.23, 1. Goggins, M., et al. 1996. Cancer Res.56, 5360. Stratton, M.R. 1996. Hum. Mol. Genet.5, 1515. Tavtigian, S.V., et al. 1996. Nat. Genet.12, 333. Rajan, J.V., et al. 1996. Proc. Natl. Acad. Sci. USA93, 13078. Spillman, M.A. and A.M. Bowcock. 1996. Oncogene13, 1639. Vaughn, J.P., et al. 1996. Cancer Res.56, 4590. Wooster, R., et al. 1995. Nature378, 789. The CAPAN-1 cell line, which has 6174delT mutation in the single BRCA2 allele, expresses a truncated BRCA2 protein of 230 kDa that contains the Anti-BRCA2 epitope and retains RAD51 binding but has lost p53 binding. Full length BRCA2 protein will co-migrate on SDS-PAGE with the catalytic subunit of DNA PK which can be detected using Anti-DNA PK, Cat. No. PC127. Antibody should be titrated for optimal results in individual systems. |
Legal Information【法律信息】 | Sold under license of U.S. Patents 5,837,492 and 6,124,104. CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany |
安全信息
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 1 |